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Introduction. Platelets bind plasminogen, its activators and contain PAI-1. Platelet 
membrane can be considered as a catalytic surface for plasminogen activation. The aim of 
this work is to investigate kinetic of plasminogen activation by tissue plasminogen activator 
(t-PA) in the presence of platelets and define inhibitory activity of platelet PAI-1. 
 
Methods. Human platelets were isolated from blood of healthy volunteers. Human Glu-
plasminogen was purified by lysine-sepharose chromatography. The rate of plasminogen 
activation by tPA was estimated by activity of new formed plasmin. Activity of platelet PAI-
1 was determined by the method developed in our lab. It is based on the inhibition of 
plasminogen activation by tPA using bovine desAB-fibrin as stimulator.  
Results. In the presence of resting platelets the catalytic efficiency of Glu-plasminogen 
activation increased in 8 times mainly thanks of Km decrease (0.184+0.066 µМ compared 
with 1.117+0.086 µМ in cell free system), catalytic constant had no significant change. 
Thrombin treatment of platelets accompanied with further increase of catalytic efficiency of 
plasminogen activation more than in 30 times. Stimulating effect of platelets was not related 
with the presence of endogenous plasminogen or its activators. PAI-1 activity of lysates of 
resting platelets and releasates of thrombin- and collagen-stimulated platelets was 2.04±0.70, 
1.26±0.60 and 0.75±0.36 IU/108 cells, respectively.  
Conclusion. Platelets stimulate plasminogen activation at physiological concentration of tPA. 
Platelets could be considered as sites of plasminogen activation and local plasmin generation. 
Platelets contain and release the active form of PAI-1 during activation. Quantitative 
assessment of its activity suggests that platelet PAI-1 makes a significant contribution to 
limiting of plasminogen activation and further fibrinolysis. The proposed method for 
quantifying PAI-1 activity in plasma and platelets can be used for evaluation of fibrinolytic 
potential in patients with cardiovascular diseases.  
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